Amitraz
A tertiary amino compound that is 1,3,5-triazapenta-1,4-diene substituted by a methyl group at position 3 and 2,4-dimethylphenyl groups at positions 1 and 5. — ChEBI
Safety documents & references
1 indexed referencesFind a product-specific SDS
Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.
Identity & molecular properties
Source-linked values| CAS number | 33089-61-1 | ChEBI ↗ |
| Molecular formula | C19H23N3 | ChEBI ↗ |
| Molar mass | 293.414 g/mol | ChEBI ↗ |
| Monoisotopic mass | 293.1892 Da | ChEBI ↗ |
| Formal charge | 0 | ChEBI ↗ |
| ChEBI identifier | CHEBI:2665 | ChEBI ↗ |
Cross-source molecular data
PubChem| Molar mass | 293.4 g/mol | PubChem ↗ |
| Exact mass | 293.189197746 Da | PubChem ↗ |
| Computed XLogP | 5.5 | PubChem ↗ |
| Topological polar surface area (Ų) | 28 | PubChem ↗ |
| H-bond donors | 0 | PubChem ↗ |
| H-bond acceptors | 2 | PubChem ↗ |
| Rotatable bonds | 4 | PubChem ↗ |
PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.
Names & structural identifiers
Copy any identifieramitrazN'-(2,4-dimethylphenyl)-N-{[(2,4-dimethylphenyl)imino]methyl}-N-methylmethanimidamideQXAITBQSYVNQDR-UHFFFAOYSA-N[H]C(=Nc1ccc(C)cc1C)N(C)C([H])=Nc1ccc(C)cc1CInChI=1S/C19H23N3/c1-14-6-8-18(16(3)10-14)20-12-22(5)13-21-19-9-7-15(2)11-17(19)4/h6-13H,1-5H3Names & synonyms
Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.
Classification & relationships
ChEBI ontologyRoles recorded in ChEBI
Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.
Safety classification · Japan
NITE / Japanese government3-methyl-1,5-di(2,4-xylyl)-1,3,5-triazapenta-1,4-diene; Amitraz · R02-B-103-MHLW, MOE
| Endpoint | Reported classification |
|---|---|
| Acute toxicity （Oral） | Category 4 |
| Skin sensitization | Category 1 |
| Carcinogenicity | Category 2 |
| Reproductive toxicity | Category 2, Additional category for effects on or via lactation |
| Specific target organ toxicity - Single exposure | Category 1 (nervous system), Category 3 (narcotic effects) |
| Specific target organ toxicity - Repeated exposure | Category 1 (central nervous system, liver) |
Selected source-reported endpoints. Other endpoints, rationales and conditions remain in the original classification. Missing or unlisted information does not mean non-hazardous. This is not a global classification or transport decision.
Read the original NITE classificationMass ↔ amount of substance
Calculated from sourced massUses 293.414 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.
Elemental composition
Theoretical mass fractionsCNHCalculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.
Research & patent references
Selected source associationsSources & record history
Checked 27 Sep 2026Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0
PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.